Schizophrenia trials in United Kingdom

In United Kingdom 22 Also abroad 473

22 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Stratification and Treatment in Early Psychosis Study - ENHANCE
Where
Cambridge, London, Oxford
Age
16 years to 40 years
People
250 worldwide
Run by
University of Oxford
See details and how to joinNCT06778564 · EU 2025-521929-32-00
Phase 3Not yet taking people in United Kingdom
Stratification and Treatment in Early Psychosis Study -ASSIST
Where
Cambridge, London, Oxford
Age
16 years to 50 years
People
250 worldwide
Run by
University of Oxford
See details and how to joinNCT07326124
Phase 3Not yet taking people in United Kingdom
Stratification and Treatment in Early Psychosis Study - PROMOTE
Where
Cambridge, London, Oxford
Age
12 years to 35 years
People
586 worldwide
Run by
University of Oxford
See details and how to joinNCT07434973
No phaseNot yet taking people in United Kingdom
Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases
Where
London
Age
16 years to 100 years
People
300
Run by
King's College London
See details and how to joinNCT07791212
No phaseTaking people
SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study
Where
London
Age
18 years and over
People
150
Run by
King's College London
See details and how to joinNCT06568081
No phaseTaking people
Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk
Where
London
Age
18 years to 40 years
People
69
Run by
King's College London
See details and how to joinNCT06224530
No phaseTaking people
The Mouth Matters in Mental Health Trial -2
Where
Ashton-under-Lyne, London, Manchester, Newcastle upon Tyne, Preston
Age
18 years and over
People
480
Run by
Lancashire and South Cumbria NHS Foundation Trust
See details and how to joinNCT07470437
Phase 2Taking people
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
Where
London, Oxford
Age
18 years to 55 years
People
120 worldwide
Run by
Neurocrine Biosciences
See details and how to joinNCT07288333 · EU 2025-521868-35-00
No phaseTaking people
A Case Series of Culturally-adapted CBTp for Black People in the UK
Where
Manchester
Age
16 years and over
People
6
Run by
University of Manchester
See details and how to joinNCT07252206
No phaseTaking people
Medical Phenotyping of NHS General Adult Psychiatry (GAP) Inpatients
Where
Livingston
Age
18 years to 65 years
People
100
Run by
University of Edinburgh
See details and how to joinNCT07398365
Phase 3Taking people
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Where
Chertsey, Crowborough, Exeter, London, Motherwell, Oxford, Sheffield
Age
55 years to 90 years
People
325 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06947941
No phaseNot yet taking people in United Kingdom
Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis
Where
London
Age
18 years and over
People
15
Run by
King's College London
See details and how to joinNCT07623928
Phase 4Taking people
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Where
London
Age
16 years to 70 years
People
2,500 worldwide
Run by
Parnassia Groep
See details and how to joinNCT05656469 · EU 2023-509680-25-00
No phaseTaking people
Early Psychosis: Investigating Cognition
Where
Nottingham
Age
18 years to 55 years
People
106
Run by
University of Nottingham
See details and how to joinNCT07196423
No phaseTaking people
Immune Mechanisms of Antipsychotic Treatment Response
Where
London
Age
18 years to 65 years
People
500
Run by
King's College London
See details and how to joinNCT06687694
No phaseTaking people
Social Isolation and Aging in Schizophrenia
Where
London
Age
40 years to 70 years
People
650 worldwide
Run by
Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07419321
No phaseTaking people
Investigating the Effect of Diroximel Fumarate on Glutathione in Schizophrenia
Where
Birmingham, London
Age
18 years to 65 years
People
30
Run by
King's College London
See details and how to joinNCT06957808
No phaseNot yet taking people in United Kingdom
Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosis (FEP)
Where
London
Age
18 years to 65 years
People
80
Run by
King's College London
See details and how to joinNCT07245212
No phaseTaking people
Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness
Where
Oxford
Age
18 years to 110 years
People
50,000
Run by
Akrivia Health
See details and how to joinNCT06641726
Phase 4Taking people
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Where
London
Age
18 years to 70 years
People
418 worldwide
Run by
Dr. Inge Winter
See details and how to joinNCT05958875 · EU 2023-506602-39-00
No phaseTaking people
Energetics and Glutamate in Schizophrenia
Where
London
Age
18 years to 65 years
People
75
Run by
King's College London
See details and how to joinNCT06236048
No phaseTaking people
E-Detection Tool for Emerging Mental Disorders
Where
Glasgow, London
Age
12 years to 35 years
People
3,000
Run by
King's College London
See details and how to joinNCT05127278